Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.
N-803/BCG Approval Signals Paradigm Shift in Management of BCG-Unresponsive NMIBC
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
ASCO Updates Advanced HCC Treatment Guideline
FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer
Iglesia Spotlights the Current Complexities of Treatment Sequencing in Advanced HCC
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm
Time to Bladder Cancer Treatment Is Similar Among Black and White Patients, But Other Disparities Persist
Dr Jia on the Evolving Role of Metastasis-Directed Radiotherapy in Prostate Cancer
Dr Wang on the Limited Utility of Quantitative Molecular Imaging Thresholds in RCC
Darolutamide Use Is Routine in Both Doublets and Triplet Therapies in mHSPC